期刊文献+

环孢霉素A和FK506对高脂血症大鼠血管内皮的影响 被引量:3

Effect of FK506 and CsA on Vascular Endothelium of Hyperlipidemic Rats
原文传递
导出
摘要 目的对比观察免疫抑制剂FK506和环孢霉素A(CsA)对高脂血症大鼠血管内皮细胞的影响。方法建立高脂血症大鼠模型,分别采用CsA〔2mg/(kg.d)〕和FK506〔0.2mg/(kg.d)〕灌喂7d进行干预,取胸主动脉HE染色观察对血管内皮的影响。采用RT-PCR和免疫组织化学染色观察血管内皮细胞中血管内皮生长因子(VEGF)、补体促衰变因子(DAF)和C反应蛋白(CRP)基因和蛋白的表达;取血清检测活性氧簇(ROS)水平。结果与FK506相比,CsA损伤高脂血症大鼠血管内皮细胞,破坏血管内皮的完整性。CsA明显抑制高脂血症大鼠血管内皮中VEGF和DAF基因和蛋白的表达,上调CRP基因和蛋白的表达,而FK506无上述干预效应。此外,CsA还能明显上调ROS水平,FK506无相似的效应。结论在高脂环境中,CsA能通过VEGF/DAF和ROS/CRP途径激活补体系统,从而导致补体所介导的血管内皮细胞的损伤;而FK506对VEGF/DAF通路和ROS/CRP表达均没有明显的影响。 Objective To observe the influence of ciclosporin A(CsA) or/and FK506 on vascular endothelium of hyperlipidemic rats.Methods Hyperlipidemic rat model was established as previously described.The injury of vascular endothelium of these rats was observed after stimulation with FK506 or/and CsA.The mRNA transcription and protein expression of the vascular endothelium growth factor(VEGF),decay-accelerating factor(DAF) and C reactive protein(CRP) in vascular endothelium of rats were measured.The serum reactive oxygen species(ROS) was detected.Results Compared with FK506,CsA was more likely to cause injury of vascular endothelium,damaging the integrity of endothelium of hyperlipidemic rats.CsA inhibited the expression of VEGF and the complement inhibitor DAF and increased the expression of CRP of vascular endothelial cells.CsA also up-regulated the serum level of ROS.FK506 showed no such impacts.Conclusion CsA can damage vascular endothelium of hyperlipidemic rats by activating the complement system induced by VEGF/DAF and ROS/CRP pathway.FK506 has no influence on the VEGF/DAF pathway and the expression of ROS/CRP.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2012年第3期305-309,共5页 Journal of Sichuan University(Medical Sciences)
基金 国家自然科学基金(批准号81101261及30600677)资助
关键词 环孢霉素A FK506 高脂血症 Ciclosporin A FK506 Hyperlipidemia
  • 相关文献

参考文献20

  • 1Gusbeth-Tatomir P,Covic A.Causes and consequences ofincreased arterial stiffness in chronic kidney disease patients.Kidney Blood Press Res,2007;30(2):97-107.
  • 2Kubrich M,Petrakopoulou P,Kofler S,et al.Impact ofcoronary endothelial dysfunction on adverse long-term outcomeafter heart transplantation.Transplantation,2008;85(11):1580-1587.
  • 3Davies SW.Clinical presentation and diagnosis of coronaryartery disease:stable angina.Br Med Bull,2001;59:17-27.
  • 4Labarrere CA,Abellada GC.Vascular anticoagulation andtransplant coronary artery disease.Z Kardiol,2000;89(Suppl9):IX/32-35.
  • 5Boratynska M,Banasik M,Watorek E,et al.Influence ofhypercholesterolemia and acute graft rejection on chronicnephropathy development in renal transplant recipients.Transplant Proc,2003;35(6):2209-2212.
  • 6Martinez Castelao A,Ramos R,Seron D,et al.Effect ofcyclosporin and tacrolimus on lipoprotein oxidation after renaltransplantation.Nefrologia,2002;22(4):364-369.
  • 7Varghese Z,Fernando RL,Turakhia G,et al.Calcineurininhibitors enhance low-density lipoprotein oxidation intransplant patients.Kidney Int Suppl,1999;71:S137-140.
  • 8Wang W,Zhang P,Wang J,et al.Cyclosporine A aggravatesvascular endothelial injury in hyperlipidemic rats by down-regulating decay-accelerating factor.Biochem Biophys ResCommun,2009;379(1):27-31.
  • 9Kotloff RM,Ahya VN.Medical complications of lungtransplantation.Eur Respir J,2004;23(2):334-342.
  • 10Mai ML,Ahsan N,Gonwa T.The long-term management ofpancreas transplantation.Transplantation,2006;82(8):991-1003.

同被引文献54

  • 1王聚乐,李长山,顿珠,周惠英.藏药结血蒿水提物的免疫抑制作用研究[J].四川大学学报(医学版),2006,37(6):908-912. 被引量:13
  • 2施国海,周佩军,王祥慧,徐达,施敏敏,陈皓.FTY720对体外混合培养淋巴细胞增殖和凋亡的影响[J].上海交通大学学报(医学版),2007,27(4):380-383. 被引量:6
  • 3Gusbeth-Tatomir P,Covic A.Causes and consequences of increased arterial stiffness in chronic kidney disease patients.Kidney Blood Press Res,2007;30(2):97-107.
  • 4Kubrich M,Petrakopoulou P,Kofler S,et al.Impact of coronary endothelial dysfunction on adverse long-term outcome after heart transplantation.Transplantation,2008,85(11):1580-1587.
  • 5Davies SW.Clinical presentation and diagnosis of coronary artery disease:stable angina.Br Med Bull,2001,59:17-27.
  • 6Labarrere CA,Abellada GC.Vascular anticoagulation and transplant coronary artery disease,Z Kardiol,2000389(Suppl 9):Ⅸ/32-35.
  • 7Turkmen K,Tonbul HZ,Erdur FM,et al.Soluble TWEAK independently predicts atherosclerosis in renal transplant patients.BMC Nephrol,2013,14:144.doi:10.1186/1471-2369-14-144.
  • 8Turanlahti MI,Taskinen M,Saarinen-Pihkala U,et al.Time-related arterial changes after allogeneic hematopoietic stem cell transplantation in children.Pediatr Res,2013,73(6):777-782.
  • 9Mitra S,Goyal T,Mehta JL.Oxidized LDL,LOX-1 and atherosclerosis.Cardiovasc Drugs Ther,2011,25(5):419-429.
  • 10Mitra S,Deshmukh A,Sachdeva R,et al.Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.Am J Med Sci,2011,342(2):135-142.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部